Production
Dedicated to manufacturing high-quality products to contribute in global healthcare
The Production Department at C2C Pharma is dedicated to excellence, manufacturing high-quality pharmaceutical products that contribute to global healthcare. Under the guidance of a dedicated team, they operate with precision and adherence to strict quality standards, ensuring efficacy, safety, and regulatory compliance. C2C’s commitment to innovation and continuous improvement drives their collaborative spirit, ensuring the production of groundbreaking products. The department upholds rigorous standards throughout the production lifecycle, ensuring pharmaceuticals of the utmost integrity.
In production area high-quality products are manufactured according to WHO GMP guidelines and local regulatory authority. At the moment C2C Pharma has production capacity to produce 350 million Tablets & 250 million Capsules per year and able to provide contract manufacturing services for both local & overseas Pharmaceuticals. Manufacturing process is conducted in accordance with authorized Batch Manufacturing Records (BMR). Packaging is controlled in accordance with authorized Batch Packaging Records (BPR). Analysis of in-process and finished product is done by IPC & QC upon information from production. Sampling and releasing of products are done by QA. The work in process and the bulk are quarantined in a separate area until the QA release is obtained. During storage of the raw materials & in process and bulk, utmost care is taken to avoid mix-up and cross-contamination by providing physical separations. Batch wise and product wise segregation is maintained.